ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC (KALIPO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00865475
Recruitment Status : Completed
First Posted : March 19, 2009
Last Update Posted : September 12, 2013
Sponsor:
Collaborator:
Abbott
Information provided by (Responsible Party):
Fundacion SEIMC-GESIDA

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2013
  Actual Study Completion Date : March 2013